Remdesivir CAS No.:1809249-37-3

When it comes to fighting a virus as deadly as COVID-19, every weapon in the arsenal is crucial. That's where Remdesivir comes in – a powerful antiviral whose effectiveness has been demonstrated time and time again. At its core, Remdesivir is a nucleotide analog that disrupts viral RNA replication by inhibiting the action of RNA polymerase. This makes it a potent inhibitor of viruses in the Coronaviridae family, including SARS-CoV-2 (COVID-19), and has the potential to be used as a therapeutic in the ongoing global pandemic.

Remdesivir is not only effective, but it is also relatively safe. The drug has a low toxicity profile and has undergone extensive clinical testing, including in rigorous randomized controlled trials. Results from one such trial conducted by the National Institute of Allergy and Infectious Diseases showed that Remdesivir shortened recovery time in hospitalized patients with COVID-19, compared with a placebo. In addition, the drug has been granted emergency use authorization by the United States Food and Drug Administration and has been listed as a critical medicine by the World Health Organization.

As a supplier of this life-saving medication, we at [Company Name] are committed to providing our customers with high-quality Remdesivir. Our product is manufactured to meet and exceed international quality standards, ensuring that it is safe and effective for patients suffering from COVID-19.

In terms of shipping and logistics, we have extensive experience in exporting pharmaceutical products around the world. We work closely with our customers to ensure that their orders are delivered efficiently and on time, no matter where they are located.

Finally, we believe that our commitment to providing high-quality products at competitive prices sets us apart from the competition. We understand the urgency of the current situation and are dedicated to ensuring that Remdesivir is accessible to as many people as possible.

In conclusion, Remdesivir is a vital weapon in the fight against COVID-19. Its efficacy, safety profile, and international recognition make it a crucial medication for patients suffering from the virus. As a manufacturer and supplier of Remdesivir, we are committed to providing our customers with high-quality, affordable medication that can help save lives. We look forward to working with you to meet the urgent need for this critical drug.

Chemical Structure : GS-5734

CAS No.: 1809249-37-3

 

GS-5734 (GS 5734;GS5734;Remdesivir)

Catalog No.: URK-V1174  Only Used For Lab.

GS-5734 (Remdesivir) is a monophosphoramidate prodrug of adenosine analogue that exhibits antiviral activity against multiple variants of EBOV (EC50=70-140 nM) and other filoviruses (EC50=0.019-1.48 uM) in cell-based assays.

Biological Activity

GS-5734 (Remdesivir) is a monophosphoramidate prodrug of adenosine analogue that exhibits antiviral activity against multiple variants of EBOV (EC50=70-140 nM) and other filoviruses (EC50=0.019-1.48 uM) in cell-based assays.
GS-5734 (Remdesivir) suppresses EBOV replication and protects 100% of EBOV-infected animals against lethal disease, ameliorating clinical disease signs and pathophysiological markers.
GS-5734 (Remdesivir) is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro.

Physicochemical Properties

References

1. Warren TK, et al. Nature. 2016 Mar 17;531(7594):381-5.

2. Jacobs M, et al. Lancet. 2016 Jul 30;388(10043):498-503.

3. Siegel D, et al. J Med Chem. 2017 Mar 9;60(5):1648-1661.

URK-V1174_COA

URK-V1174_SDS

URK-V1174_TDS

 

Note: All products of Ureiko are only used for scientific research or drug certificate declaration, and we do not provide products and services for any personal use!

Why choose us?

• We have a reputation for being reliable and trustworthy.
• We take the market as the guide and development as the theme, and continuously promote the sustainable and rapid development of the enterprise.
• We are committed to continuous improvement and innovation.
• Since its establishment, our company has been striving to meet customers' expectations with innovative thinking and improving production concept.
• We provide our clients with access to the latest advances in Antibiotics & Antivirals Library technology.
• Our company's Remdesivir CAS No.:1809249-37-3 have been continuously improved in variety, output and quality, and are well received by domestic and foreign users.
• We have a proven track record of delivering on-time and on-budget.
• Our company takes science and technology as the first priority and pays attention to the construction of R&D team, which rapidly improves the precision and quality stability of our products.
• Our products are backed by a comprehensive warranty.
• We strive to form a strong quality enterprise and enhance the core competitiveness of the enterprise.

Hot Tags: remdesivir cas no.:1809249-37-3, China remdesivir cas no.:1809249-37-3, agonists for protein protein interactions, agonists in pharmaceutical research, agonists for nuclear receptor activation, inhibitors for pathogen recognition, agonists for mitochondrial function, inhibitors for cell therapy